21724-96-9

Basic information

• Product Name: 1H-Pyrrole-2,5-dione, 3-(4-bromophenyl)-
• Synonyms: 3-(4-bromo-phenyl)-pyrrole-2,5-dione;3-(4-Brom-phenyl)-pyrrol-2,5-dion;3-(4-bromo-phenyl)-1H-pyrrole-2,5-dione
• CAS NO: 21724-96-9
• Molecular Formula: C10H6BrNO2
• Molecular Weight: 252.067
• Mol File: 21724-96-9.mol

Chemical Properties

• Melting Point: 206 - 209 °C
• Boiling Point: 404.1±45.0 °C(Predicted)
• Density: 1.687±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 1H-Pyrrole-2,5-dione, 3-(4-bromophenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrrole-2,5-dione, 3-(4-bromophenyl)-(21724-96-9)
• EPA Substance Registry System: 1H-Pyrrole-2,5-dione, 3-(4-bromophenyl)-(21724-96-9)

Safety Data

• Hazardous Substances Data: 21724-96-9(Hazardous Substances Data)

Usage

Derivative of pyrrole

A modified version of the parent compound pyrrole, which is a five-membered heterocyclic ring containing one nitrogen atom.

Presence of bromine atom

A halogen atom (bromine) attached to the phenyl ring at the 4-position, which influences the compound's properties and reactivity.

Potential applications in pharmaceutical and organic synthesis

The compound can be used as an intermediate or building block in the synthesis of various pharmaceuticals and organic compounds.

Development of new materials

The unique structure and properties of the compound make it a valuable component in creating novel materials with specific functions or characteristics.

Synthesis of biologically active compounds and functional materials

The compound can be used to create molecules with specific biological activities or properties that can be applied in various fields, such as medicine or materials science.

Potential hazardous nature

Due to its chemical composition and structure, the compound may pose certain risks or hazards, and should be handled with care to ensure safety.

Upstream product

• 541-59-3 maleiimide 
• 98-58-8 4-bromobenzenesulfonyl chloride 
• 106-40-1 4-bromo-aniline 
• 2028-85-5 (4-bromophenyl)diazonium chloride 

Downstream Products

• 1259556-38-1 ethyl 1-(4-bromophenyl)-2,4-dioxo-3-aza-bicyclo[3.1.0]hexane-6-carboxylate 
• 1259556-41-6 tert-butyl 1-(4-bromophenyl)-6-(methoxymethyl)-3-aza-bicyclo[3.1.0]hexane-3-carboxylate 
• 1259556-40-5 tert-butyl 1-(4-bromophenyl)-6-(hydroxymethyl)-3-aza-bicyclo[3.1.0]hexane-3-carboxylate 
• 1259556-39-2 1-[(4-bromophenyl)-3-azabicyclo[3.1.0]hex-6-yI]methanol 
• 1259556-66-5 tert-butyl 6-((3,4-dichlorophenoxy)methyl)-1-(4-bromophenyl)-3-aza-bicyclo[3.1.0]hexane-3-carboxylate 

Relevant articles and documents

Approach to the Synthesis of Unsymmetrical/Symmetrical Maleimides via Desulfitative Arylation at Different Temperatures

New routes toward selective synthesis of both mono-and diaryl maleimides have been innovated. The mere requirement to this end is through the increase of temperature. The method works effectively for maleic anhydride and maleic acid as well. Also, the fir

Selective and tunable synthesis of 3-arylsuccinimides and 3-arylmaleimides from arenediazonium tetrafluoroborates and maleimides

A highly efficient synthetic strategy for synthesizing 3-arylsuccinimides has been developed from arenediazonium tetrafluoroborates and maleimides in the presence of TiCl3. The reactions generated 3-arylsuccinimides in satisfactory yields under mild reaction conditions. In addition, 3-arylmaleimides were obtained by the coupling of arenediazonium tetrafluoroborate and maleimides catalyzed by CuCl. This methodology provided the selective and tunable synthesis of two classes of products by simply switching different metal reagents. The methods are simple, efficient and practical.

NOVEL AZABICYCLOHEXANES

The present invention relates to novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof.

NOVEL AZABICYCLOHEXANES

The present invention relates to novel compounds of Formula (I), their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof.

AZABICYCLO[3.1.0] HEXYLPHENYL DERIVATIVE AS MODULATORS OF DOPAMINE D3 RECEPTORS

The present invention relates to novel compounds of formula (IA) or a salt thereof: Formula (IA), wherein: A is attached to the phenyl group at the meta position or the para position relative to the cyclopropyl group, and is selected from the group consis